Anti-angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt-1

Anti-angiogenesis gene therapy has attracted interest as a potential treatment for hepatocellular carcinoma (HCC). Studies have indicated that soluble fms-like tyrosine kinase-1 (sFlt-1) may suppress angiogenesis by sequestering free vascular endothelial growth factor (VEGF) or by forming inactive h...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guanglin, Miao, Fei, Zhu, Jinhai, Chen, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865760/
https://www.ncbi.nlm.nih.gov/pubmed/28849176
http://dx.doi.org/10.3892/mmr.2017.7310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865760/
https://www.ncbi.nlm.nih.gov/pubmed/28849176
http://dx.doi.org/10.3892/mmr.2017.7310

Ejemplares similares